Hong Kong plays a pivotal role in the global realm of biomedicine constantly fuelling the healthcare industry with innovations. This session covers the extensive translation support in Hong Kong for disruptive breakthroughs in healthcare research, including the applications of next-generation genetic sequencing and medical AI to identify at-risk populations, target-oriented precision medicines, point-of-care diagnostics and the use of biosensors and trackers which improve care and treatment outcomes. We will also discuss the opportunities for investment and the potential of biomedical development in Hong Kong and Greater Bay Area.

 

Riding the Health of Innovations – Invest in Hong Kong Biotech, JW Marriott, Los Angeles, CA 

http://www.hktdc.com/ncs/thinkasiathinkhk2019/en/s/info-program.html